Happy New Year! Certainly, I hope you had a relaxing time over the holidays with family and friends as well as a great start into the new year. 2019 was a real landmark year for Golden Helix. Please let me mention a few highlights:
- We launched VSClinical AMP in June 2019: This product is supporting the clinical variant interpretation based on ACMG & AMP guidelines. The product was an instant success.
- We received another $1.2M research grant from the NIH. This allows us to build out the most advanced clinical workflow solution interpreting next-gen sequencing data. A particular focus on this work is to deeply integrate CNV analytics capabilities in this context.
- Last but not least, Inc 5000 selected us among the fastest-growing private companies in the United States.
Read the full story on Our 2 SNPs… here.